Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2013

01-07-2013 | Epidemiology

Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study

Authors: Victoria Blinder, Sujata Patil, Carolyn Eberle, Jennifer Griggs, Rose C. Maly

Published in: Breast Cancer Research and Treatment | Issue 2/2013

Login to get access

Abstract

Low-income women may be especially vulnerable to job loss after a breast cancer diagnosis. The identification of early risk factors for not returning to work in the long term could inform interventions to help survivors avoid this outcome. A consecutive sample of low-income, employed, underinsured/uninsured women treated for stage 0–III breast cancer was surveyed 6, 18, 36, and 60 months after diagnosis. Participants were classified according to the survey in which they first reported return to work. If they were not working in every survey they were classified as not returning to work. Correlates of not returning to work were identified. Of 274 participants, 36 % returned to work by 6 months, an additional 21 % by 18, 10 % by 36, and 5 % by 60 months. 27 % never returned to work. Of those not working at 6 months, 43 % never returned. Independent predictors of never returning to work included lowest annual income (<$10,000), Latina ethnicity, high comorbidity burden, and receipt of chemotherapy. Very poor women who stop working during chemotherapy for breast cancer are at risk of not returning to work months and years following treatment. These findings may have clinical and policy implications. Conversely, radiation therapy, axillary node dissection, age, and job type do not appear to be associated with return to work. Clinicians should discuss work-related concerns with patients and facilitate early return to work when desired by the patient. Additional research is needed to develop interventions to optimize return to work.
Literature
1.
go back to reference Blinder V, Patil S, Thind A, Diamant A, Hudis C, Basch E, Maly R (2012) Return to work in low-income latina non-latina white breast cancer survivors: a three-year longitudinal study. Cancer 118(6):1664–1674. doi:10.1002/cncr.26478 PubMedCrossRef Blinder V, Patil S, Thind A, Diamant A, Hudis C, Basch E, Maly R (2012) Return to work in low-income latina non-latina white breast cancer survivors: a three-year longitudinal study. Cancer 118(6):1664–1674. doi:10.​1002/​cncr.​26478 PubMedCrossRef
2.
go back to reference Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D (2003) Predictors of quality of life of breast cancer patients. Acta Oncol 42(7):710–718PubMedCrossRef Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D (2003) Predictors of quality of life of breast cancer patients. Acta Oncol 42(7):710–718PubMedCrossRef
5.
go back to reference Bouknight RR, Bradley CJ, Luo Z (2006) Correlates of return to work for breast cancer survivors. J Clin Oncol 24(3):345–353PubMedCrossRef Bouknight RR, Bradley CJ, Luo Z (2006) Correlates of return to work for breast cancer survivors. J Clin Oncol 24(3):345–353PubMedCrossRef
6.
go back to reference Satariano WA, DeLorenze GN (1996) The likelihood of returning to work after breast cancer. Public Health Rep 111(3):236–241PubMed Satariano WA, DeLorenze GN (1996) The likelihood of returning to work after breast cancer. Public Health Rep 111(3):236–241PubMed
7.
go back to reference Bradley CJ, Neumark D, Bednarek HL, Schenk M (2005) Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ 24(1):137–160PubMedCrossRef Bradley CJ, Neumark D, Bednarek HL, Schenk M (2005) Short-term effects of breast cancer on labor market attachment: results from a longitudinal study. J Health Econ 24(1):137–160PubMedCrossRef
8.
go back to reference Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ (2010) The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat 119(1):213–220. doi:10.1007/s10549-009-0389-y PubMedCrossRef Mujahid MS, Janz NK, Hawley ST, Griggs JJ, Hamilton AS, Katz SJ (2010) The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat 119(1):213–220. doi:10.​1007/​s10549-009-0389-y PubMedCrossRef
10.
go back to reference Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M (2009) Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer 45(4):625–633. doi:10.1016/j.ejca.2008.09.027 PubMedCrossRef Peuckmann V, Ekholm O, Sjogren P, Rasmussen NK, Christiansen P, Moller S, Groenvold M (2009) Health care utilisation and characteristics of long-term breast cancer survivors: nationwide survey in Denmark. Eur J Cancer 45(4):625–633. doi:10.​1016/​j.​ejca.​2008.​09.​027 PubMedCrossRef
11.
go back to reference Chen J, Diamant A, Thind A, Maly R (2008) Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer 112(5):1153–1161PubMedCrossRef Chen J, Diamant A, Thind A, Maly R (2008) Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer 112(5):1153–1161PubMedCrossRef
12.
go back to reference Eremenco SL, Cella D, Arnold BJ (2005) A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 28(2):212–232PubMedCrossRef Eremenco SL, Cella D, Arnold BJ (2005) A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 28(2):212–232PubMedCrossRef
13.
go back to reference Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94(1):39–49PubMedCrossRef Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94(1):39–49PubMedCrossRef
14.
go back to reference Seeman TE, Berkman LF (1988) Structural characteristics of social networks and their relationship with social support in the elderly: who provides support. Soc Sci Med 26(7):737–749PubMedCrossRef Seeman TE, Berkman LF (1988) Structural characteristics of social networks and their relationship with social support in the elderly: who provides support. Soc Sci Med 26(7):737–749PubMedCrossRef
15.
go back to reference Marin G, Sabogal F, Marin B, Otero-Sabogal R, Perez-Stable E (1987) Development of a short acculturation scale for hispanics. Hispanic J Behav Sci 9(2):183–205CrossRef Marin G, Sabogal F, Marin B, Otero-Sabogal R, Perez-Stable E (1987) Development of a short acculturation scale for hispanics. Hispanic J Behav Sci 9(2):183–205CrossRef
18.
go back to reference Chirikos TN, Russell-Jacobs A, Cantor AB (2002) Indirect economic effects of long-term breast cancer survival. Cancer Pract 10(5):248–255PubMedCrossRef Chirikos TN, Russell-Jacobs A, Cantor AB (2002) Indirect economic effects of long-term breast cancer survival. Cancer Pract 10(5):248–255PubMedCrossRef
19.
go back to reference Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Hellemann G (2007) Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res 16(3):413–428PubMedCrossRef Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Hellemann G (2007) Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res 16(3):413–428PubMedCrossRef
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef
21.
go back to reference Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34(1):73–84PubMedCrossRef Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34(1):73–84PubMedCrossRef
23.
go back to reference Maly RC, Liu Y, Leake B, Thind A, Diamant AL (2010) Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication. Breast Cancer Res Treat 119(3):707–716. doi:10.1007/s10549-009-0418-x PubMedCrossRef Maly RC, Liu Y, Leake B, Thind A, Diamant AL (2010) Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication. Breast Cancer Res Treat 119(3):707–716. doi:10.​1007/​s10549-009-0418-x PubMedCrossRef
25.
go back to reference Brown RF, Owens M, Bradley C (2013) Employee to employer communication skills: balancing cancer treatment and employment. Psychooncology 22(2):426–433. doi:10.1002/pon.2107 PubMed Brown RF, Owens M, Bradley C (2013) Employee to employer communication skills: balancing cancer treatment and employment. Psychooncology 22(2):426–433. doi:10.​1002/​pon.​2107 PubMed
26.
go back to reference Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC
27.
go back to reference Greenhouse S (2013) Labor sees bright spots in membership trends. The New York Times, January 28 Greenhouse S (2013) Labor sees bright spots in membership trends. The New York Times, January 28
Metadata
Title
Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study
Authors
Victoria Blinder
Sujata Patil
Carolyn Eberle
Jennifer Griggs
Rose C. Maly
Publication date
01-07-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2625-8

Other articles of this Issue 2/2013

Breast Cancer Research and Treatment 2/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine